Opendata, web and dolomites

Nano-OligoMed SIGNED

Hybrid Nanostructured Oligonucleotide Platforms for Biomedical Applications

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Nano-OligoMed project word cloud

Explore the words cloud of the Nano-OligoMed project. It provides you a very rough idea of what is the project "Nano-OligoMed" about.

mimics    therapeutic    technological    academic    oligonucleotide    electronics    combine    intrinsic    breakthroughs    combination    exchange    extra    international    educational    inert    degradable    oligonucleotides    transfer    decades    drugs    experts    last    collaborative    internalization    competences    networking    strategies    cell    function    nanomaterials    safe    hybrid    young    scientific    joint    chemical    molecular    oligomed    systemic    scientists    diversity    dna    carrier    sciences    activation    network    responsive    phd    nano    biology    possibility    programmable    skills    material    efficient    cancer    broadening    students    received    materials    biomedicine    team    payload    enabled    artificial    interaction    input    multidisciplinary    rigid    nanotechnology    degradation    silica    agents    training    medicine    countries    ambition    generate    delicate    arise    sectors    drug    mobility    senior    mirnas    bio    creation    structures   

Project "Nano-OligoMed" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITE DE STRASBOURG 

Organization address
address: RUE BLAISE PASCAL 4
city: STRASBOURG
postcode: 67081
website: http://www.unistra.fr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 598˙500 €
 EC max contribution 598˙500 € (100%)
 Programme 1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
 Code Call H2020-MSCA-RISE-2017
 Funding Scheme MSCA-RISE
 Starting year 2017
 Duration (year-month-day) from 2017-12-01   to  2021-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITE DE STRASBOURG FR (STRASBOURG) coordinator 180˙000.00
2    UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA IT (ROMA) participant 162˙000.00
3    UNIVERSITA DEGLI STUDI DI PARMA IT (PARMA) participant 130˙500.00
4    NANOMOL TECHNOLOGIES SL ES (CERDANYOLA DEL VALLES) participant 126˙000.00
5    ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING MCGILL UNIVERSITY CA (MONTREAL) partner 0.00
6    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA US (OAKLAND CA) partner 0.00
7    UNIVERSIDAD DE LA HABANA CU (PLAZA) partner 0.00

Map

 Project objective

Nanotechnology has received widespread attention in the last several decades due to the technological breakthroughs it has enabled across sectors from electronics to medicine. Towards the great challenges that nanotechnology arise, Nano-OligoMed has the ambition to establish and support a network of international collaboration, enabling a collaborative scientific team to effectively use a diversity of approaches and strategies to generate and test hybrid nanomaterials for the efficient and safe systemic delivery of oligonucleotide-based therapeutic agents. To this end, we have set-up a joint multidisciplinary scientific collaborative programme that through exchange, international mobility, and strongly collaborative transfer of knowledge and training activities between 4 European and 3 extra-European countries, will bring together leading experts under the field of “nanomaterials in biomedicine”. The scientific aim of Nano-OligoMed is the creation of degradable hybrid structures that combine the rigid, inert silica with the delicate programmable oligonucleotides or artificial oligonucleotide-mimics. The possibility to develop novel oligonucleotide-based materials will enable a) the degradation of the drug carrier at the presence of a specific input as a function of the intrinsic bio-responsive feature of oligonucleotides, b) the activation of a therapeutic function as a result of the bio-molecular interaction between the oligonucleotide-based material and the molecular target (i.e. miRNAs) and c) the delivery of the chemical payload (DNA and/or artificial mimics, even in combination with cancer drugs) upon cell internalization. The international academic networking, the broadening of the research skills, the educational activities, will provide to young (PhD students) and senior scientists, specific competences in the field of materials sciences, nanotechnology, molecular biology and molecular medicine.

 Deliverables

List of deliverables.
Protocols for the characterization of the behavior of hybrid supramolecular nanostructures Other 2020-02-12 16:29:25
DNA/PNA-BioMSNPs Other 2020-02-07 12:43:53
School on synthesis and characterization of hybrid materials for medical applications Other 2020-02-07 12:44:16
Protocol for the study of stimuli-responsive DNA nanomachines Other 2019-10-10 12:56:42
Porous silicon nanoparticles Other 2019-10-10 12:56:28
Protocol for the synthesis of DNA, its modification and conjugation with FRET pair and small molecules Other 2019-10-10 12:56:30
Project website Websites, patent fillings, videos etc. 2019-10-10 12:56:29

Take a look to the deliverables list in detail:  detailed list of Nano-OligoMed deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NANO-OLIGOMED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NANO-OLIGOMED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.3.)

CONMECH (2019)

Nonsmooth Contact Dynamics

Read More  

MAIL (2019)

Identifying Marginal Lands in Europe and strengthening their contribution potentialities in a CO2sequestration strategy

Read More  

RADON (2020)

Irradiation driven nanofabrication: computational modelling versus experiment

Read More